The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations

Michael M. Santiago Pfizer (NYSE:PFE) is a blue chip dividend stock whose medications, product candidates, and vaccines play one of the key roles in the fight against various types of cancer, viruses, immuno-inflammatory, infectious, cardiovascular, and rare diseases. Thesis Since the end of December 2021, Pfizer's share price has fallen more than 54%, reaching a strong support level. This decline can be attributed to the sharp drop in demand for its COVID-19 vaccine, investor concerns about losing exclusiv ...